Dynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024 PR Newswire EMERYVILLE, Calif., April 24, 2024 EMERYVILLE, Calif. , April 24, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report first quarter 2024 financial results on Wednesday, May 8, 2024 , after the U.S. financial markets close. Dynavax will host a conference call and...